FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FDX last trade $267.72, up ~5.4% as of 12:41 UTC (Nov 12). Market move: guidance steadies peak‑season nerves FedEx shares are outperforming today after executives told investors at the Baird Global Industrial Conference that fiscal Q2 adjusted EPS will exceed last year’s $4.05, a tone that helped boost the stock into the afternoon. Several outlets echoed the message that improved profitability is expected this quarter despite a choppy macro backdrop. investors.fedex.com+1 Coverage notes the company is navigating a ~$1 billion full‑year headwind from the U.S. elimination of the “de minimis” import exemption, yet management emphasized levers to keep margins resilient.
12 November 2025
Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is back in the headlines today after pricing a $7 million underwritten public offering tied to its pending business combination with Decoy Therapeutics. The company said the deal is expected to close “on or about November 12, 2025,” pending customary conditions, including consummation of the Decoy transaction. PR Newswire Key takeaways What happened today (Nov. 12, 2025) Salarius confirmed the pricing of its offering for gross proceeds of ~$7 million before fees. The package includes: The company notes the registration statement on Form S‑1 (File No. 333‑284368) became effective on Nov. 10, 2025, and the
IBM Unveils ‘Nighthawk’ & ‘Loon’ Quantum Chips: Targets 2026 Quantum Advantage and 2029 Fault Tolerance

IBM Unveils ‘Nighthawk’ & ‘Loon’ Quantum Chips: Targets 2026 Quantum Advantage and 2029 Fault Tolerance

IBM announced two new quantum processors—Nighthawk and Loon—plus major Qiskit software upgrades and a community “advantage tracker,” aiming for verified quantum advantage by 2026 and fault‑tolerant systems by 2029. Stock ticks higher on the news. What happened today At its annual Quantum Developer Conference, International Business Machines Corporation (NYSE: IBM) unveiled two headline advances for quantum computing: IBM Quantum Nighthawk, a 120‑qubit processor built to push toward near‑term quantum advantage in 2026, and IBM Quantum Loon, an experimental architecture that demonstrates all the core hardware elements needed for fault‑tolerant quantum computing on a 2029 timeline. IBM also detailed significant Qiskit
12 November 2025
Leifras Co., Ltd. (NASDAQ: LFS) Rockets Nearly 600%; Premarket Pullback on Nov. 12, 2025 — Catalyst, Context, and What’s Next

Leifras Co., Ltd. (NASDAQ: LFS) Rockets Nearly 600%; Premarket Pullback on Nov. 12, 2025 — Catalyst, Context, and What’s Next

Shares of youth‐sports operator Leifras Co., Ltd. (LFS) exploded higher in Tuesday’s U.S. session, then eased in early Wednesday trading as investors digested the move. Leifras’ American Depositary Shares closed Tuesday up 576.79% at $11.37, with after‑hours trading adding ~4.2% to $11.85; by premarket Wednesday, LFS was indicated lower, trading around the high‑$9s to low‑$10s range. Benzinga+1 What happened Why it moved: a new municipal contract + fresh fundamentals How Tuesday’s surge fits the bigger picture By the numbers (latest known) What to watch next About Leifras Leifras describes itself as a sports and social business company focused on youth
12 November 2025
Bitcoin Slides to ~$103K as Morgan Stanley Flags ‘Fall Season’; XRP and Crypto Retreat After Veterans Day — What to Watch on Nov. 12, 2025

Bitcoin Slides to ~$103K as Morgan Stanley Flags ‘Fall Season’; XRP and Crypto Retreat After Veterans Day — What to Watch on Nov. 12, 2025

Bitcoin extended its early‑week slide on Wednesday, briefly touching the ~$103,000 area as risk assets digested soft U.S. labor readings, a still‑unresolved (but improving) government shutdown backdrop, and a fresh caution from Morgan Stanley that crypto has entered the “fall” phase of its four‑year cycle. XRP and other majors also slipped after a choppy Veterans Day session, with market breadth skewing lower across large‑cap tokens. Barron’s+2 Key takeaways Market snapshot (as of publication) What Morgan Stanley just said — and why it matters Morgan Stanley published a fresh episode of its Thoughts on the Market podcast on Nov. 11, where
12 November 2025
AMD Targets $100B in Data‑Center Revenue Within Five Years as Analyst Day Sets 60% CAGR Ambition (Nov. 12, 2025)

AMD Targets $100B in Data‑Center Revenue Within Five Years as Analyst Day Sets 60% CAGR Ambition (Nov. 12, 2025)

AMD says its data‑center business will compound at ~60% over the next 3–5 years, aiming for $100B in annual sales, >$20 EPS and a leading AI platform spanning MI450 “Helios” racks (2026) and MI500 (2027). Shares rose after the event. Reuters+2Reuters+2 What happened today (Nov. 12) Advanced Micro Devices’ Financial Analyst Day (held Nov. 11 in New York) is reverberating through markets today. AMD laid out aggressive long‑term targets—>$100 billion in annual data‑center revenue within five years, ~60% CAGR for the data‑center segment, >35% company‑wide CAGR, and non‑GAAP EPS above $20 over the next 3–5 years. In premarket trade Wednesday,
12 November 2025
Scott Bessent Faces Fresh Scrutiny Over Medicare‑Tax ‘Limited Partner’ Loophole and an Unkept Back‑Taxes Pledge — What’s New on Nov. 12, 2025

Scott Bessent Faces Fresh Scrutiny Over Medicare‑Tax ‘Limited Partner’ Loophole and an Unkept Back‑Taxes Pledge — What’s New on Nov. 12, 2025

Treasury Secretary Scott Bessent is back under the microscope over his past use of a Medicare self‑employment tax loophole commonly claimed by hedge‑fund managers and other partnership owners. Senate Democrats have alleged since January that Bessent avoided roughly $900,000 in Medicare taxes by classifying himself as a limited partner of his own fund, Key Square Group—an approach the IRS has increasingly challenged in court. During his confirmation process, Bessent said he would pay any contested Medicare tax if ultimately owed, but the matter remains unresolved publicly and pressure has intensified again today. AP News+3Roll Call+3Politico+3 What’s new today (Nov. 12)
12 November 2025
NJ Transit Commuter Alert for Nov. 12, 2025: Portal Bridge Cutover to Trigger 6 Weeks of Service Changes; Weather Delays Earlier This Week; River Line Takeover Update

NJ Transit Commuter Alert for Nov. 12, 2025: Portal Bridge Cutover to Trigger 6 Weeks of Service Changes; Weather Delays Earlier This Week; River Line Takeover Update

What’s happening now: a 6‑week Portal Bridge “cutover” NorthJersey.com reports that the track cutover to the new Portal North Bridge will occur over roughly six weeks, during which some trains will be rerouted or canceled while crews move operations from the old swing bridge to the new structure. Specific dates and schedules have not yet been released, but agencies are signaling a significant, time‑boxed disruption to facilitate the switch. Yahoo Why this matters The current Portal Bridge—on the busy Northeast Corridor just west of Secaucus Junction—has long been a reliability risk because it must open for river traffic and sometimes
12 November 2025
Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Published: Nov. 12, 2025 (updated intraday, UTC) Key points at a glance What’s happening today (Nov. 12, 2025) 1) Shareholders vote on employee option exchange Moderna is holding a virtual special meeting at 8:00 a.m. Eastern to seek approval for a one‑time exchange of “underwater” employee stock options (Executive Committee excluded). Per the definitive proxy, at 100% participation the plan would cancel options for ~5.65M shares and regrant options for ~2.21M, reducing option overhang by ~3.44M shares. The webcast URL and meeting logistics are outlined in the SEC filing. SEC+1 Why it matters: Lower option overhang can reduce prospective dilution
12 November 2025
AMD Targets $100B Data‑Center Revenue and 35%+ Growth: Stock Lifts After Analyst Day — Nov. 12, 2025

AMD Targets $100B Data‑Center Revenue and 35%+ Growth: Stock Lifts After Analyst Day — Nov. 12, 2025

Published: Wednesday, November 12, 2025 Summary: Advanced Micro Devices, Inc. (NASDAQ: AMD) set aggressive new long‑term targets at its New York Financial Analyst Day, including a push to $100 billion in annual data‑center chip revenue within five years, a company‑wide 35%+ revenue CAGR, and non‑GAAP EPS above $20 over the next 3–5 years. Management also outlined a multi‑year AI hardware roadmap (MI400 in 2026 and MI500 in 2027) and a rack‑scale “Helios” system to challenge Nvidia’s platform lead. AMD shares moved higher in pre‑market trading on Wednesday following the event. Reuters+2Reuters+2 What AMD announced Context: Bloomberg notes AMD expects >35%
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck & Co., Inc. (NYSE: MRK) extended this week’s rally on Wednesday as investors digested fresh late‑stage results for its investigational oral PCSK9 inhibitor and an FDA clearance that supports broader precision use of Keytruda-based therapy. Below is what changed today and how it fits into Merck’s 2025 storyline. Today’s highlights at a glance Market move: why MRK is in focus today Merck shares traded higher on Wednesday after back‑to‑back catalysts in cardiometabolic and oncology. The stock’s strength follows AHA 2025 presentations showing that enlicitide—a once‑daily oral PCSK9 inhibitor—cut LDL‑C by 55.8% at 24 weeks vs. placebo in broad hypercholesterolemia
12 November 2025
‘Lucifer’ Bee with Devil‑Like Horns Discovered in Western Australia — What We Know Today (Nov. 12, 2025)

‘Lucifer’ Bee with Devil‑Like Horns Discovered in Western Australia — What We Know Today (Nov. 12, 2025)

A newly described species of native leafcutter bee sporting tiny, devil‑like facial “horns” has been unveiled by researchers in Western Australia’s Goldfields. The species, formally named Megachile (Hackeriapis) lucifer, was first collected in 2019 during a survey of pollinators around a critically endangered wildflower, Marianthus aquilonaris, and is now detailed in a peer‑reviewed paper in the Journal of Hymenoptera Research. Curtin University+1 Why scientists are buzzing about Megachile lucifer The female bees carry a conspicuous pair of forward‑curving “horns” on the clypeus (the front of the face) — a feature not seen in males. Researchers say the structures are sub‑millimetre
12 November 2025

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop